Gene Query: ACTR1B

Dataset Description Geneva Score
Adaptation of a RAS pathway activation signature from FF to FFPE tissues in colorectal cancer (FFPE RNA-Seq II) 47.9
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 26.57
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 26.53
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 26.53
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 25.48
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 24.81
Transcriptional profile of CAOV2 ovarian cancer cells with TAZ silencing 21.71
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 18.89
FOXD3 is a novel tumor suppressor in lung cancer 18.84
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 17.5
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 17.5
Nrf2 regulated genes in A549 cells 17.34
Identification of Nrf2 regulated genes by RNA sequencing 17.34
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 16.55
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 15.41
RNA-Seq from early time points in the kidney differentiation protocol 12.9
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 12.53
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 12.46
Identification of diverse target RNAs that are functionally regulated by human Pumilio proteins 12.32
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 12.17
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 12.06
Acquired resistance to MEK-CDK4/6 inhibitor combinations in cutaneous melanoma 11.99
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 11.35
Transcriptome of U251 cells overexpression complement component 7 11.16
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 11.06
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 11.02
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 10.91
RNA-seq analysis of uveal melanoma cells treated with FR900359 10.84
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 10.46
Essential Roles of SETD7 as Transcriptional Activator and Co-regulator of H3K36me in Cardiac Lineage Commitment 10.42
Thymine DNA Glycosylase as a novel target for melanoma: effect of TDG silencing on gene expression in SK-mel-28 melanoma cells 10.31
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 10.29
HNRNPL and its RNA Targets in Prostate Cancer 10.29
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 10.27
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 10.26
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 10.07
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 10.01
RNAseq analysis of ESRP regulated splicing events in prostate cancer 10.0
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 9.84
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 9.81
Genome wide expression change in LCC2 and MCF-7 cells 9.79
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 9.67
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 9.61
Iron response of HepG2 cells 9.47
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 9.46
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 9.44
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 9.39
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 9.22
Gene expression profile using RNA-seq in WC00060 or SR-0788 cells transfected with siRNA for KPC1 or control 9.19
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 9.18
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 9.13
CpG dinucleotides introduced into gag can inhibit HIV-1 gene expression by modulating pre-mRNA splicing 8.99
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 8.92
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 8.75
RNA-seq of human foreskin fibroblast cells lacking RB and/or p130 after doxorubicin treatment 8.66
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 8.65
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 8.62
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 8.58
Model systems of DUX4 expression recapitulate the transcriptional profile of FSHD cells 8.53
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 8.52
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 8.43
Real-time observation of light-controlled transcription in living cells 8.41
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 8.33
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 8.3
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 8.27
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 8.22
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_1A_PI3K_RNA-seq] 8.19
Transcriptomics profiling of Alzheimer’s disease reveal novel molecular targets 8.11
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 8.05
Functional role of SLIT2 and ROBO1 in trophoblasts 8.04
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 8.02
Single-cell RNA-Seq Investigation of Foveal and Peripheral Expression in the Human Retina 7.85
MicroRNA (miR)-211 loss promotes metabolic vulnerability and BRAF inhibitor sensitivity in melanoma 7.79
Transcriptome analysis of U87 cells upon LINC00152 knockdown 7.74
MeRIP-seq for heat shock in B-cell lymphoma cells 7.61
Overexpression of NFIB and YBX1 in MCF-7 cells 7.59
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 7.57
Over expression of Receptor Activity Modifying Protein 2 in HEK293T cells 7.5
Transcriptional profiling of MDA-MB-231 and its ρ0 cells (lacking mtDNA) after 48h arginine depletion by arginine deiminase (ADI). 7.49
Understanding the reproducibility and robustness of the kidney organoid differentiation protocol using RNA-seq 7.43
The LIN28B/let-7 axis is a novel therapeutic pathway in Multiple Myeloma 7.42
The role of FAM46C in myeloma cells 7.34
The role of FAM46C in myeloma cells [sequencing] 7.34
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 7.31
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 7.25
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [K562] 7.21
Major roles of cyclobutane pyrimidine dimers, nucleotide excision repair and ATR in the alternative splicing response to UV irradiation 7.2
Molecular characterization of BRSK2 and BRSK1 kinases as negative regulators of the NRF2 transcription factor 7.17
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 7.14
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function 7.09
Open chromatin mapping identifies transcriptional networks regulating human epididymis epithelial function [Rnase-Seq] 7.09
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 7.07
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 7.07
Ro60-knockout cells 7.06
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 7.02
The DPYSL2 gene connects mTOR and schizophrenia 7.02
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 6.97
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 6.97
Biological effect of chronic mistranslation in mammalian cells 6.85
ETV7 and interferon response 6.82
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 6.82
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 6.77
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 6.77
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 6.75
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 6.7
circRNA-sequencing 6.68
Transcriptome profiling of self-renewing hESCs and multipotent mesoderm progenitor cells as a function of substrate stiffness 6.66
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 6.64
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 6.53
Region-specific Innate Antiviral Responses of the Human Epididymis 6.51
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 6.47
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 6.42
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 6.33
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 6.3
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 6.29
Hijacking of stress response machinery by oncogenes in acute leukaemia 6.29
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 6.28
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 6.28
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 6.28
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 6.28
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 6.26
The effect of PPARG inhibition on human angiomyolipoma cells 6.25
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 6.21
Lipid degradation promotes prostate cancer cell survival 6.19
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 6.16
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 6.16
A RUNX2-mediated Epigenetic Regulation of the Survival of p53 Defective Cancer Cells 6.13
RNA-seq of YB5 cells treated with Proscillaridin A 6.09
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 6.08
Effect of mitochondria deficiency on senescence-associated gene expression 6.07
Global transcriptional profiling changes upon knockdown of LKB1 in human glioblastoma cell lines 6.06
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 6.05
TFAP2C signalling in human fibroblasts 6.04
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 6.03
A role for ZNF598 in post-transcriptional gene regulation 6.03
RNA-seq in transgenic cells 6.01
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 6.01
RNA-seq data of adipocytes co-cocultured with OVCAR5 in Boyden chamber (4d) 5.96
Intrahepatic MAIT cell gene expression revealed by RNA-seq 5.96
Unraveling cis-regulatory elements by mapping structural changes in mRNAs 5.85
Analysis of transcrptomes of Danon patient derived hiPSC-cardiomyocytes by RNA-deep Sequencing 5.85
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 5.81
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 5.79
Expression and functions of long noncoding RNAs during human T helper cell differentiation 5.75
The ribosomal prolyl-hydroxylase OGFOD1 decreases during cardiac differentiation, modulates translation and spliceosomal processes 5.75
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 5.75
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 5.73
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.67
Tumor exosome integrins determine organotropic metastasis 5.66
Integrated Systems Biology Analysis of KSHV Latent Infection Reveals Viral Induction and Reliance on Peroxisome Mediated Lipid Metabolism 5.62
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 5.6
RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients 5.58
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 5.58
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 5.57
RNA seq data of Hep3B-control, Hep3B-sertraline, Hep3B-XL413, Hep3B-XL413-sertraline, Huh7-control, Huh7-sertraline, Huh7-XL413, Huh7-XL413-sertraline cells 5.57
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 5.56
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 5.56
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 5.51
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 5.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 5.5
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 5.5
Trnascriptome analysis of HeLa cells infected with rTHOV-wt, -dML, -SW mutant or mock-treated 5.47
Transcriptome-wide analysis of IL2RA enhancer activation by CRISPRa 5.46
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 5.46
SOX21 ensures rostral forebrain identity by suppression of WNT8B during neural regionalization of human embryonic stem cells 5.44
Whole transcriptome analysis of PBMCs stimulated with either a P. aeruginosa phage PNM lysate or with its bacterial host P. aeruginosa 5.39
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 5.35
Transcriptome sequencing of human coronary artery smooth muscle cell under treatment of nitrated fatty acid 5.33
RNA-seq of cells with TET1 knockout 5.31
A histone H3.3 Lysine 36 Trimethylation Reader Connects Chromatin to Regulated Pre-mRNA Processing 5.29
Macrophage Ad5f35 M2 Challenge 5.29
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 5.28
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 5.28
RNA expression profiles from HUVECs overexpressing adenovirally delivered HIF1a and HIF2a proteins 5.28
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.27
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 5.27
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 5.27
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 5.23
Mapping interactions for the TNIP2 hub protein 5.23
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 5.2
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 5.2
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 5.2
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 5.2
Gene expression analysis of human CD8+ T cells treated with a DOT1L inhibitor 5.17
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 5.13
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 5.13
Cystathionine-β-Synthase Promotes Colon Carcinogenesis 5.13
A novel P300 inhibitor reverses DUX4-mediated global histone H3 hyperacetylation, target gene expression and cell death 5.12
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 5.12
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 5.12
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 5.07
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 5.07
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 5.06
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 5.05
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 5.05
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner [Huh-7] 5.04
IGF2BP1 promotes SRF-dependent transcription in cancer in a m6A- and miRNA-dependent manner 5.04
CROP-Seq in Primary Human T Cells 5.03
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 5.0
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation [RNA-Seq] 4.99
Dynamic and stable enhancer-promoter contacts regulate terminal differentiation 4.99
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 4.98
Differentiation of human embryonic stem cells to HOXA+ hemogenic vasculature that resembles the aorta-gonad-mesonephros 4.94
RNA-seq analysis of control and Myc-induced U2OS cells 4.91
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 4.9
Chromatin-informed inference of transcriptional programs in gynecologic cancers [RNA-Seq] 4.9
Chromatin-informed inference of transcriptional programs in gynecologic cancers 4.9
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 4.89
Identifying the molecular mode of action of itraconazole in colorectal cancer 4.86
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 4.86
Global Mapping of Human RNA-RNA Interactions 4.84
Quiescent glioblastoma cells shift to an epithelial-mesenchymal transition-like gene program 4.84
High-throughput sequencing of pluripotent cells 4.84
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 4.84
Functional role of CPPED1 in trophoblasts. 4.83
DAOY-NERT2 Notch/Hypoxia Transcriptome Analysis 4.8
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 4.75
In Vitro and In Vivo Modulation of Alternative Splicing by the Biguanide Metformin. 4.74
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 4.74
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 4.72
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 4.7
Identification of renal resident macrophages across species [C1] 4.69
The influence of PPFIA1 silencing to gene expression in breast carcinoma cell line and head and neck squamous cell carcinoma cell lines by RNA-sequencing in three dimensional collagen I 4.68
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 4.66
Therapeutic targeting of GCB- and ABC-DLBCLs by rationally designed BCL6 inhibitors 4.65
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 4.63
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 4.63
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer. 4.63
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis [RNA-seq] 4.61
EZH2 and BCL6 cooperate to assemble CBX8-BCOR Polycomb complex to repress bivalent promoters, mediate germinal center formation and promote lymphomagenesis 4.61
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 4.57
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 4.57
Genomic basis for clinical response to histone deacetylase inhibition in advanced urothelial carcinoma 4.57
Regulation of highly expressed hCINAP on translatome 4.56
Coordination of neuron production in mouse and human cerebral cortex by the homolog of Drosophila Mastermind protein 4.53
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA-Seq] 4.53
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 4.47
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.46
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.46
Single-cell analysis of adult human ovary using 10X genomics 4.44
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 4.44
SETBP1-WT and SETBP1-G870S epigenetic landscapes 4.44
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 4.43
The cohesin complex prevents Myc-induced replication stress 4.39
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 4.39
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 4.39
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.37
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 4.35
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 4.33
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas [RNA-Seq] 4.33
c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas 4.33
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 4.27
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 4.19
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 4.16
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 4.12
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 4.12
RNA transcriptome analysis during HSV-1 infection 4.12
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 4.11
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 4.11
Human Long Intergenic Noncoding RNA Linc-ADAL Knockdown in Mature Adipocytes using Lentiviral ShRNA 4.1
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 4.06
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 4.02
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 3.98
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 3.97
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 3.96
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 3.96
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 3.96
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.95
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 3.95
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 3.94
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 3.87
In situ CAPTURE of chromatin interactions by biotinylated dCas9 3.87
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 3.87
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 3.85
The mRNA export receptor NXF1 coordinates transcriptional dynamics, alternative polyadenylation and mRNA export 3.85
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 3.82
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 3.81
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 3.8
Identification of Sin3B regulated genes during quiescence 3.75
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 3.74
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 3.74
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 3.74
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 3.72
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 3.72
RNA seq with AML (NB4) cells upon FTO inhibition 3.69
Acetyl-CoA carboxylase inhibition regulates microtubule dynamics and intracellular transport in cystic fibrosis epithelial cells 3.67
Global gene expression profiles of cardiac progenitors differentiated from human pluripotent stem cells in 3D culture under simulated microgravity 3.66
Lysine benzoylation is a novel histone mark 3.64
Lysine benzoylation is a novel histone mark [RNA-seq] 3.64
RNA-seq of ASXL2 shRNA KD in SKNO-1 cells 3.62
Subclonal cooperation drives metastasis through modulating local and systemic immune microenvironments 3.61
Global gene expression profiles of cardiomyocytes differentiated from human pluripotent stem cells (hiPSC-CMs) in 3D culture exposed to ethanol 3.61
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 3.57
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 3.54
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 3.54
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression 3.53
DUX4-induced histone variants H3.X and H3.Y mark DUX4 target genes for expression (RNA-seq) 3.53
Controlling for gene expression changes in transcription factor protein networks. 3.49
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 3.46
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.38
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.38
A SRp55-regulated alternative splicing network controls pancreatic beta cell survival and function 3.35
RNAseq of cell lines with knocked in ESR1 mutations 3.31
Transciptomic profiling of human fetal lung samples 3.28
Illumina sequencing of vaginal epithelial cells from women using depot medroxyprogesterone acetate or non-hormonal contraception 3.25
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 3.22
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 3.21
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 3.21
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 3.17
The RNA helicase DDX39B regulates IL7R alternative splicing reducing the risk of Multiple Sclerosis 3.16
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 3.1
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.06
ARID1A is a critical regulator of luminal identity and therapeutic response in oestrogen receptor-positive breast cancer (RNA-Seq) 3.06
The cytokine environment influence on human skin-derived T cells 3.05
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 3.01
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [RNA-Seq] 2.97
H1609088 Human RNA-Sequencing 2.97
Illumina Total RNA-seq in HeLa 2.96
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.96
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.96
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 2.92
The Hippo pathway kinase LATS1 scaffolds Beclin1 in autophagy regulation in hepatocellular carcinoma 2.92
Transcriptomic analysis of acute mitochondrial pyruvate carrier inhibition using UK5099 in ABL prostate cancer cells 2.91
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 2.91
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 2.88
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 2.85
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 2.85
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 2.84
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 2.79
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 2.78
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.78
Targeted enhancer activation by a subunit of the integrator complex 2.76
N6-methyladenine DNA Modification in Glioblastoma 2.73
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.73
RNA-seq differential expression studies: more sequence, or more replication? 2.73
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 2.72
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 2.7
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 2.7
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 2.68
ZBTB10 binds the telomeric variant repeat TTGGGG and interacts with TRF2 [RNA-Seq] 2.68
TWIST1-induced microRNA-424 drives an intermediate epithelial-to-mesenchymal transition that opposes metastasis 2.67
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 2.64
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.63
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.62
ARS2 is a general suppressor of pervasive transcription [RNAseq] 2.62
Energy Metabolism during Anchorage-Independence 2.59
Multiple roles for Grainyheadlike transcription factors in the establishment and maintenance of human mucociliary airway epithelium 2.56
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.54
Ribosome profiling upon inhibition of eIF4A 2.51
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 2.49
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 2.49
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection 2.39
Self-organized cerebral organoids with human specific features predict effective drugs to combat Zika virus infection [RNA-seq] 2.39
The MEF2B Regulatory Network - RNA-seq data 2.39
The MEF2B Regulatory Network 2.39
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.38
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 2.38
mRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancer 2.36
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 2.34
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.23
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 2.22
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 2.22
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 2.21
Defective removal of ribonucleotides from DNA promotes systemic autoimmunity 2.18
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 2.18
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 2.18
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 2.17
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 2.14
Heterogeneous effects of massive hypoxia pathway activation in kidney cancer 2.08
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 2.08
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 2.08
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 2.05
Impeding transcription of expanded microsatellite repeats by deactivated Cas9 2.04
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 2.01
Activity-dependent transcriptional changes in human neurons 1.96
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.94
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 1.81
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 1.81
Redifferentiation of expanded human islet β cells by inhibition of ARX 1.75
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 1.7
Interaction between mitoNEET and NAF-1 in cancer cells 1.65
RNAseq in Alzheimer's Disease patients 1.63
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 1.62
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells (RNA-seq) 1.59
Targeted transcriptional modulation with type I CRISPR-Cas systems in human cells 1.59
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 1.56
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 1.55
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 1.54
Regulation of hypoxia-inducible factor activity by ZMYND8 1.53
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 1.51
Regulating Interleukin-2 activity with engineered receptor signaling clamps 1.49
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 1.48
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.46
Amiloride, an old diuretic drug, is a potential therapeutic agent for multiple myeloma 1.46
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 1.45
Dnmt3a and Dnmt3b associate with enhancers to regulate human epidermal stem cell homeostasis 1.44
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 1.43
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 1.43
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 1.4
Genome wide transcript and miRNAanalysis of invitro and in-vivo generated human cardiac samples 1.39
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.37
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 1.37
Expression profiling of MCF-7 cells with treatment of TCDD 1.35
Expression profiling of MCF-7 cells with 10nM treatment of TCDD 1.35
Identification of renal resident macrophages across species 1.32
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 1.28
Human islets of varying quality: the good, the (not so) bad and the ugly 1.27
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.27
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.27
Genome-Wide Transcriptional Regulation Mediated By Biochemically Distinct Forms of SWI/SNF 1.26
Combinatorial Regulation Mediated by Biochemically Distinct Forms of SWI/SNF [RNA-Seq] 1.26
Measure transcript integrity using RNA-seq data 1.26
U2AF1 mutations alter splice site recognition in hematological malignancies 1.23
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.23
Ectoderm specification of H1 human embryonic stem cells 1.21
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 1.19
Gene expression profile in breast cancer cells 1.19
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 1.16
Genetic and Epigenetic Landscapes of Laterally Spreading Tumors of the Colorectum 1.15
Transcriptome data of temporal and cingulate cortex in the Rett syndrome brain 1.14
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.12
Myeloid-derived suppressor cells facilitie invasion and metastasis of papillary thyroid cancer cells by repressing miR-486-3p 1.09
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 1.08
RNA editing in nascent RNA affects pre-mRNA splicing 1.06
miRNAs affected by antagomiR-17 treatment 1.05
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates [RNA-seq] 1.03
Genome-wide mapping of DROSHA cleavage sites on primary microRNAs and novel substrates 1.03
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 1.02
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 1.01
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 0.99
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 0.99
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.99
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 0.97
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.97
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells 0.95
A novel transcriptional network for the Androgen Receptor in human epididymis epithelial cells [RNA-Seq] 0.95
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.93
Identification of downstream genes regulated by YAP1 through knockdown and overexpression of YAP1 in U251 cell with a stably expression of mutant APP 0.92
Mutational landscape of splicing genes and functional consequences across 33 cancer types 0.91
Inhibition of the integrin alpha-V beta-3 reverts the paradoxical effect of levothyroxine replacement during bexarotene therapy in cutaneous T-cell lymphoma 0.91
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 0.9
Effects of transcription on genome - nuclear lamina interactions 0.9
HNRNPM-regulated splicing dependencies in prostate cancer 0.87
HNRNPM-regulated splicing dependencies in prostate cancer [RNA-Seq] 0.87
KMT2C medaites the estrogen dependence of breast cancer through regulation of ERα enhancer function 0.86
Gene expression profile of multiple myeloma cell lines treated with CB-5083 0.85
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 0.82
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.82
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.82
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 0.82
Transcriptome analysis of RANK-positive and RANK-negative luminal progenitor subpopulations in the human breast 0.81
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 0.79
Gene expression changes due to PARP knockdown in human cells 0.77
Tracing Enhancer Networks using Epigenetic Traits (TENET) 0.76
Targets of ROR2 overexpression in MCF-7 cells revealed a differentially regulated module of non-canonical WNT signaling pathway 0.76
Functional significance of the HIV-1 Tat signature amino acid residues 0.75
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.7
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 0.69
Function and hormonal regulation of GATA3 in human first trimester placentation 0.68
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 0.67
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.64
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.63
Gene expression profile of melanoma cell lines after overexpression or knockdown of KPC1 0.6
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 0.59
RNA-seq characterization of downstream effects of upregulating SMN2 via down-regulating PRC2 or blocking the PRC2:SMN-AS1 interaction with a mixmer oligonucleotide 0.56
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells 0.55
Role of NuRD subunits CHD3 and CHD4 in human melanoma cells (RNA-seq) 0.55
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 0.55
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.54
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.49
The bromodomain protein BRD4 regulates splicing during heat shock 0.48
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.47
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.46
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.46
RNA Expression Profile of Calcified Bicuspid, Tricuspid and Normal Human Aortic Valves by RNA Sequencing [TAV] 0.46
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.39
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.33
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas [RNA-seq] 0.32
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas 0.32
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.29
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 0.29
RNA-seq of MDA-MB-231 cells with TET1 knockout 0.28
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 0.28
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 0.23
Comparative Analysis of Cas9 Activators Across Multiple Species 0.23
Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements 0.23
The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression [ELL2 rescue] 0.16
DAOY-Notch1/Notch2 knockout: transcriptome comparison 0.14
ChIP-seq and RNA-seq analysis of KMT2D-silenced metastatic melanoma cells 0.13
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.12
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.12
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 0.1
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 0.09
PolyA-sequencing in IMR-32 neuroblastoma cells with shRNA mediated depletion of CDK12, CDK13 or GFP. 0.08
Transcriptomic analysis of ERR alpha orphan nuclear receptor 0.07
Ribosomal protein RPL26 is the principal target of UFMylation 0.07
RNA-Seq analysis of human colorectal cancer with liver metastasis 0.06
RNA sequencing and pathway analysis identify important pathways involved in hypertrichosis and intellectual disability in patients with Wiedemann-Steiner syndrome 0.06
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.03
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation